HC Wainwright & Co. Reiterates Buy on OPKO Health, Maintains $3 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on OPKO Health (NASDAQ:OPK) and maintained a price target of $3.
August 07, 2023 | 10:26 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OPKO Health's stock may see positive movement due to the reiterated 'Buy' rating and maintained price target by HC Wainwright & Co.
Analyst ratings and price targets can significantly influence a stock's performance. In this case, the 'Buy' rating and $3 price target for OPKO Health by HC Wainwright & Co. could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100